MedPath
NMPA Approval

Pemetrexed Disodium for Injection

国药准字H20249345

November 15, 2024

Drug Information

注射用培美曲塞二钠

注射剂

0.2g(按C₂₀H₂₁N₅O₆计)

化学药品

November 15, 2024

Company Information

Applicant Company

连云港经济技术开发区花果山大道567-11号楼5-6层

Manufacturing Company

连云港市振华路 18 号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用培美曲塞二钠 - NMPA 批准文号 | MedPath